Literature DB >> 20208527

Methylphenidate facilitates learning-induced amygdala plasticity.

Kay M Tye1, Lynne D Tye, Jackson J Cone, Evelien F Hekkelman, Patricia H Janak, Antonello Bonci.   

Abstract

Although methylphenidate (Ritalin) has been used therapeutically for nearly 60 years, the mechanisms by which it acutely modifies behavioral performance are poorly understood. Here we combined intra-lateral amygdala in vivo pharmacology and ex vivo electrophysiology to show that acute administration of methylphenidate, as well as a selective dopamine transporter inhibitor, facilitated learning-induced strengthening of cortico-amygdala synapses through a postsynaptic increase in AMPA receptor-mediated currents, relative to those in saline-treated rats. Furthermore, local administration of methylphenidate in the lateral amygdala enhanced cue-reward learning through dopamine D1 receptor-dependent mechanisms and suppressed task-irrelevant behavior through D2 receptor-dependent mechanisms. These findings reveal critical and distinct roles for dopamine receptor subtypes in mediating methylphenidate-induced enhancements of neural transmission and learning performance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20208527      PMCID: PMC2988577          DOI: 10.1038/nn.2506

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  44 in total

1.  Organization of projections to the lateral amygdala from auditory and visual areas of the thalamus in the rat.

Authors:  N N Doron; J E Ledoux
Journal:  J Comp Neurol       Date:  1999-09-27       Impact factor: 3.215

Review 2.  Long-term potentiation--a decade of progress?

Authors:  R C Malenka; R A Nicoll
Journal:  Science       Date:  1999-09-17       Impact factor: 47.728

3.  A functional role for dopamine transmission in the amygdala during conditioned fear.

Authors:  F A Guarraci; R J Frohardt; S L Young; B S Kapp
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

4.  Enhanced acquisition of discriminative approach following intra-amygdala d-amphetamine.

Authors:  P K Hitchcott; C J Harmer; G D Phillips
Journal:  Psychopharmacology (Berl)       Date:  1997-08       Impact factor: 4.530

5.  More frequent diagnosis of attention deficit-hyperactivity disorder.

Authors:  J M Swanson; M Lerner; L Williams
Journal:  N Engl J Med       Date:  1995-10-05       Impact factor: 91.245

6.  Orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning.

Authors:  G Schoenbaum; A A Chiba; M Gallagher
Journal:  Nat Neurosci       Date:  1998-06       Impact factor: 24.884

7.  Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm.

Authors:  E W Lamont; L Kokkinidis
Journal:  Brain Res       Date:  1998-06-08       Impact factor: 3.252

Review 8.  Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

Authors:  M V Solanto
Journal:  Behav Brain Res       Date:  1998-07       Impact factor: 3.332

9.  Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity.

Authors:  I D Waldman; D C Rowe; A Abramowitz; S T Kozel; J H Mohr; S L Sherman; H H Cleveland; M L Sanders; J M Gard; C Stever
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

10.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.

Authors:  N D Volkow; G J Wang; J S Fowler; S J Gatley; J Logan; Y S Ding; R Hitzemann; N Pappas
Journal:  Am J Psychiatry       Date:  1998-10       Impact factor: 18.112

View more
  35 in total

1.  Effect of amphetamine place conditioning on excitatory synaptic events in the basolateral amygdala ex vivo.

Authors:  A Hetzel; G E Meredith; D J Rademacher; J A Rosenkranz
Journal:  Neuroscience       Date:  2012-01-18       Impact factor: 3.590

2.  Modulation of social influence by methylphenidate.

Authors:  Daniel K Campbell-Meiklejohn; Arndis Simonsen; Mads Jensen; Victoria Wohlert; Trine Gjerløff; Jørgen Scheel-Kruger; Arne Møller; Chris D Frith; Andreas Roepstorff
Journal:  Neuropsychopharmacology       Date:  2012-02-08       Impact factor: 7.853

3.  Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats.

Authors:  E J Marijke Achterberg; Linda W M van Kerkhof; Ruth Damsteegt; Viviana Trezza; Louk J M J Vanderschuren
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

4.  Plasticity at Thalamo-amygdala Synapses Regulates Cocaine-Cue Memory Formation and Extinction.

Authors:  Matthew T Rich; Yanhua H Huang; Mary M Torregrossa
Journal:  Cell Rep       Date:  2019-01-22       Impact factor: 9.423

Review 5.  Optogenetic investigation of neural circuits underlying brain disease in animal models.

Authors:  Kay M Tye; Karl Deisseroth
Journal:  Nat Rev Neurosci       Date:  2012-03-20       Impact factor: 34.870

6.  Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: a perfusion fMRI study.

Authors:  Junghoon Kim; John Whyte; Sunil Patel; Eduardo Europa; Jiongjiong Wang; H Branch Coslett; John A Detre
Journal:  Psychopharmacology (Berl)       Date:  2011-12-28       Impact factor: 4.530

7.  Amygdala-hippocampal innervation modulates stress-induced depressive-like behaviors through AMPA receptors.

Authors:  Hui Ma; Chenyang Li; Jinpeng Wang; Xiaochen Zhang; Mingyue Li; Rong Zhang; Zhuo Huang; Yong Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

Review 8.  Establishing causality for dopamine in neural function and behavior with optogenetics.

Authors:  Elizabeth E Steinberg; Patricia H Janak
Journal:  Brain Res       Date:  2012-09-29       Impact factor: 3.252

Review 9.  Neural Circuit Motifs in Valence Processing.

Authors:  Kay M Tye
Journal:  Neuron       Date:  2018-10-24       Impact factor: 17.173

10.  Genetic reconstruction of dopamine D1 receptor signaling in the nucleus accumbens facilitates natural and drug reward responses.

Authors:  Bryan B Gore; Larry S Zweifel
Journal:  J Neurosci       Date:  2013-05-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.